T-cell lymphoma secondary to checkpoint inhibitor therapy
Anand et al.
Journal for ImmunoTherapy of Cancer
February 2020
Authors and Affiliates
Anand K1, Ensor J2, Pingali SR3, Hwu P4,5, Duvic M4, Chiang S3, Miranda R4, Zu Y3, Iyer S6;
1
Houston Methodist Cancer Center, Houston, Texas, USA kartikanand88@gmail.com spiyer@mdanderson.org.
2
Houston Methodist Research Institute, Houston, Texas, USA.
3
Houston Methodist Cancer Center, Houston, Texas, USA.
4
University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
5
Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
6
University of Texas MD Anderson Cancer Center, Houston, Texas, USA kartikanand88@gmail.com spiyer@mdanderson.org.